Advil Dual Action Earns American Dental Association Seal of Acceptance

CHICAGO, Sept. 23, 2024 — The American Dental Association (ADA) today announced that Advil® Dual Action is the first over-the-counter pain reliever to earn its Seal of Acceptance for safe and effective temporary management of acute dental pain.

The ADA Council on Scientific Affairs awarded Advil Dual Action – which contains both ibuprofen and acetaminophen – the Seal in a new category called “Orally Administered Analgesic for the Temporary Management of Acute Dental Pain.” Advil Dual Action is sold by Haleon.

This new category supports ADA-endorsed clinical practice guidelines that recommend non-steroidal anti-inflammatory drugs (NSAIDs) alone or in combination with acetaminophen as a first line therapy for short-term dental pain. For most short-term dental pain, whether as a result of a dental procedure or when dental care is not immediately available, a strong body of evidence shows that these over-the-counter products can help patients manage pain more effectively than prescription opioid medications.

"For many years, dentists have embraced recommending NSAIDs taken alone or with acetaminophen as an effective way to help their patients manage dental pain, and the evidence supports that," said Dr. Purnima Kumar, chair of the ADA Council on Scientific Affairs. “The ADA Seal helps make the choice clearer in a moment when someone needs dental pain relief.”

The ADA recommends patients seek professional help when experiencing dental pain and that patients with short-term dental pain use the product as directed until they can see a dentist.

The ADA Seal of Acceptance program was established in 1931 to assist dental professionals in making informed recommendations concerning the safety and efficacy of consumer products. Members of the ADA Council on Scientific Affairs review product submissions, including data from clinical studies demonstrating safety and efficacy, and only award the Seal when specific categorical requirements are met. More than 400 products currently carry the Seal.

“As a brand that’s been trusted for over 40+ years on all types of aches and pains, Advil is focused on providing powerful relief at the source of pain. Advil Dual Action combines two pain fighting ingredients – Acetaminophen and Ibuprofen – and clinical studies show that the combination of ingredients is stronger and lasts longer than ibuprofen and regular strength acetaminophen alone*. We’re proud that Dual Action has now been recognized by the ADA as a reliable, safe and effective pain reliever for short-term dental pain,” said Karen Bouhadana, Senior Brand Director, Advil.

For more information about the ADA Seal program, visit ADA.org/Seal. Learn more about the ADA’s guidance on oral pain relief at ADA.org/painmanagement.

*compared to acetaminophen 650mg or ibuprofen 250mg

About Haleon U.S.
Haleon (NYSE: HLN) is a leading global consumer health company with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Wellness. Built on trusted science, innovation, and deep human understanding, Haleon's U.S. brands include Abreva, Advil, Benefiber, Centrum, Emergen-C, Excedrin, Flonase, Gas-X, Nexium, Nicorette, Parodontax, Polident, Preparation H, Pronamel, Sensodyne, Robitussin, Theraflu, TUMS, Voltaren, and more. For more information on Haleon and its brands, please visit www.haleon.com or contact USMediaRelations@haleon.com.

About the American Dental Association
The not-for-profit ADA is the nation's largest dental association, representing 159,000 dentist members. The premier source of oral health information, the ADA has advocated for the public's health and promoted the art and science of dentistry since 1859. The ADA's state-of-the-art research facilities develop and test dental products and materials that have advanced the practice of dentistry and made the patient experience more positive. The ADA Seal of Acceptance has long been a valuable and respected guide to consumer dental care products. The Journal of the American Dental Association (JADA), published monthly, is the ADA's flagship publication and the best-read scientific journal in dentistry. For more information about the ADA, visit ADA.org. For more information on oral health, including prevention, care and treatment of dental disease, visit the ADA's consumer website MouthHealthy.org.

The ADA Forsyth Institute was founded in 1910 as the Forsyth Dental Infirmary for Children (later, the Forsyth Institute), to provide dental care to the disadvantaged children of Boston. While continuing to serve children in need, yet recognizing the ultimate goal is to prevent dental disease, the Institute in 1915 began to focus on scientific research and is today the world’s leader in oral health research. In October of 2023, the Institute joined with the American Dental Association to form the ADA Forsyth Institute, a 501(c)(3) entity dedicated to improving people’s oral and overall health and powering the profession of dentistry through cutting-edge basic research, creative translational science, innovative clinical technologies, and global public health outreach. Consistent with the Institute’s founding mission, the ADA ForsythKids mobile dental program continues to serve children in need.